An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally...

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• p38 mitogen-activated protein (MAP) kinase is a key regulator of inflammatory responses.
• Previous work identified RPR200765A, a pyridine-imidazole inhibitor of p38 MAP kinase, effective in arthritis models.
• There is a need for novel, orally bioavailable inhibitors of p38 MAP kinase for inflammatory diseases.

Purpose of the Study:

• To synthesize and evaluate a novel library of pyrimidine-imidazole based compounds targeting p38 MAP kinase.
• To optimize synthetic strategies for improved efficiency and compound bioavailability.
• To identify potent and orally bioavailable p38 MAP kinase inhibitors for further development.

Main Methods:

• Solid-phase combinatorial organic synthesis was employed for library generation.
• The Monte Carlo Monomer Selection algorithm was used to maximize synthetic efficiency and bioavailability.
• Polymer-supported quench techniques facilitated purification of the synthesized compounds.
• High-throughput screening using p38 kinase and permeability assays enabled rapid compound evaluation.

Main Results:

• A library of pyrimidine-imidazole compounds with two points of structural variability was synthesized.
• The Monte Carlo Monomer Selection algorithm enhanced combinatorial synthesis and bioavailability.
• The polymer-supported quench technique proved effective for purification.
• Several potent and orally bioavailable p38 MAP kinase inhibitors were identified.

Conclusions:

• Novel pyrimidine-imidazole scaffolds represent a promising class of p38 MAP kinase inhibitors.
• Combinatorial synthesis coupled with computational algorithms can accelerate drug discovery.
• The identified compounds warrant further investigation for their therapeutic potential in inflammatory diseases.